All articles tagged with #health and economics
The article discusses how US government subsidies for crops like corn, soy, and wheat promote the consumption of unhealthy, processed foods, contributing to obesity and related health issues, which in turn drive up healthcare costs. Despite dietary guidelines promoting fruits and vegetables, these receive minimal subsidies, leading to a diet that favors refined grains and processed foods, exacerbating public health problems and economic burdens.
Goldman Sachs predicts that the widespread use of new weight-loss drugs in the US could increase the country's GDP by 1% in the coming years, as lower obesity-related complications are expected to improve workplace efficiency. The market for weight-loss drugs is projected to reach $100 billion annually by the end of the decade, with Novo Nordisk and Eli Lilly leading the race. The use of GLP-1 agonists, pursued by several companies, could potentially increase by 10 to 70 million consumers by 2028, leading to significant economic spillovers. This wave of healthcare innovation, combined with the use of weight-loss drugs, could raise the US GDP by 1.3% in the coming years.